The 1 analysts offering 12-month price forecasts for Aridis Pharmaceuticals Inc have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The median estimate represents a +2,198.85% increase from the last price of 0.09.
The current consensus among 1 polled investment analysts is to Buy stock in Aridis Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share --
Reporting Date Feb 28
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.